(Q47357954)

English

Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial

scientific article published in March 1995

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/7869205

Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/7869205

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Ohls RK

1

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/7869205

Osborne KA

2

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/7869205

Christensen RD

3

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/7869205

language of work or name

0 references

publication date

1 March 1995

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/7869205

The Journal of Pediatrics

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/7869205

126

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/7869205

3

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/7869205

421-426

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/7869205

Erythropoietin and neonatal anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

Recombinant human erythropoietin vs transfusions in the treatment of anemia of prematurity. A cost-benefit analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

A randomized, double-blind, placebo-controlled trial of recombinant erythropoietin in treatment of the anemia of bronchopulmonary dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

Portal Venous and Aortic Glucose and Lactate Changes in a Chronically Catheterized Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

Relationship between determinants of oxygen delivery and respiratory abnormalities in preterm infants with anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

Anemia of prematurity: determinants of the erythropoietin response

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

Decreased response of plasma immunoreactive erythropoietin to "available oxygen" in anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

Direct evidence for erythropoietin-induced release of endothelin from peripheral vascular tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

BQ123, an ETA receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

Erythropoietin affects the maturation pattern of fetal G-CSF-responsive progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970462-0

7 January 2021

Identifiers

10.1016/S0022-3476(95)70462-0

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/7869205

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 January 2018

http://europepmc.org/abstract/MED/7869205

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47357954&oldid=2153340614"